Cargando…

Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry

OBJECTIVE: To explore real-life use of glucose lowering drugs and prognosis after acute myocardial infarction (AMI) with a special focus on metformin. METHODS: Patients (n = 70270) admitted for AMI 2012–2017 were stratified by diabetes status and glucose lowering treatment and followed for mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritsinger, Viveca, Lagerqvist, Bo, Lundman, Pia, Hagström, Emil, Norhammar, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919225/ https://www.ncbi.nlm.nih.gov/pubmed/33231125 http://dx.doi.org/10.1177/1479164120973676

Ejemplares similares

Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes
por: Ritsinger, Viveca, et al.
Publicado: (2021)

Cohort profile: Data standards for cardiac rehabilitation structure and processes for the SWEDEHEART cardiac rehabilitation (SWEDEHEART-CR) registry
por: Leosdottir, Margret, et al.
Publicado: (2023)

Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry
por: Norlund, Fredrika, et al.
Publicado: (2018)

Management and outcome trends in type 2 myocardial infarction: an investigation from the SWEDEHEART registry
por: Eggers, K. M., et al.
Publicado: (2023)

Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
por: Figtree, Gemma A., et al.
Publicado: (2022)

Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry
por: Eggers, Kai M., et al.
Publicado: (2021)

Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c
por: Karayiannides, Stelios, et al.
Publicado: (2021)

Increased Physical Activity Post–Myocardial Infarction Is Related to Reduced Mortality: Results From the SWEDEHEART Registry
por: Ekblom, Orjan, et al.
Publicado: (2018)

Physical inactivity and smoking after myocardial infarction as predictors for readmission and survival: results from the SWEDEHEART-registry
por: Ek, Amanda, et al.
Publicado: (2018)

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
por: Allahyari, Ali, et al.
Publicado: (2020)

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data
por: Kristófi, Robin, et al.
Publicado: (2022)

History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case–control study
por: Ritsinger, Viveca, et al.
Publicado: (2023)

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006–2019: a registry-based cohort study
por: Leosdottir, Margret, et al.
Publicado: (2023)

Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials
por: Berry, Colin, et al.
Publicado: (2017)

Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry
por: Alabas, Oras A, et al.
Publicado: (2017)

Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence‐Based Care in Heart Disease Evaluated According to Recommended Therapies)
por: Varenhorst, Christoph, et al.
Publicado: (2018)

Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
por: Trevisan, Marco, et al.
Publicado: (2020)

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
por: Persson, Jonas, et al.
Publicado: (2023)

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
por: Allahyari, Ali, et al.
Publicado: (2020)

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
por: Meziani, Sara, et al.
Publicado: (2022)

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
por: Lind, Viktor, et al.
Publicado: (2021)

Correction to: Mortality and Cardiovascular Outcomes in Patients Presenting With Non‐ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
Publicado: (2023)

Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry
por: Dworeck, Christian, et al.
Publicado: (2020)

Development and Validation of a Novel Risk Score for In‐Hospital Major Bleeding in Acute Myocardial Infarction:—The SWEDEHEART Score
por: Simonsson, Moa, et al.
Publicado: (2019)

Patient experience of the informed consent process during acute myocardial infarction: a sub-study of the VALIDATE-SWEDEHEART trial
por: Olsson, Anneli, et al.
Publicado: (2020)

External validation of the SWEDEHEART score for predicting in-hospital major bleeding among East Asian patients with acute myocardial infarction
por: Liu, Yabin, et al.
Publicado: (2023)

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014
por: Szummer, Karolina, et al.
Publicado: (2017)

International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries()()
por: McNamara, R.L., et al.
Publicado: (2014)

Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013
por: Mohammad, Moman A, et al.
Publicado: (2018)

Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study
por: Sarajlic, Philip, et al.
Publicado: (2021)

Reliability of estimating left ventricular ejection fraction in clinical routine: a validation study of the SWEDEHEART registry
por: Lenell, Joel, et al.
Publicado: (2022)

Assessing the external validity of the VALIDATE-SWEDEHEART trial
por: Rylance, Rebecca T, et al.
Publicado: (2021)

Biobank linked to SWEDEHEART quality registry—routine blood sample collection opens new opportunities for cardiovascular research
por: Baron, Tomasz, et al.
Publicado: (2019)

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry
por: Patel, Ashish, et al.
Publicado: (2018)

Prognostic value of early sustained ventricular arrhythmias in ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: A substudy of VALIDATE-SWEDEHEART trial
por: Demidova, Marina M., et al.
Publicado: (2022)

ST-Elevation Myocardial Infarction, Thrombus Aspiration, and Different Invasive Strategies. A TASTE Trial Substudy
por: Fröbert, Ole, et al.
Publicado: (2015)

Association of peptidoglycan recognition protein 1 to post‐myocardial infarction and periodontal inflammation: A subgroup report from the PAROKRANK (Periodontal Disease and the Relation to Myocardial Infarction) study
por: Rathnayake, Nilminie, et al.
Publicado: (2022)

Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry
por: Mamadjanov, Temur, et al.
Publicado: (2021)

Impact of Marital Status on Management and Outcomes of Patients With Acute Myocardial Infarction: Insights From the China Acute Myocardial Infarction Registry
por: Wei, Zhi‐Yao, et al.
Publicado: (2022)

Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
por: Wester, Axel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8avfiidnlfhbhtimsej2dfvs0k